Journal Basic Info
**Impact Factor calculated based on Google Scholar Citations. Please contact us for any more details.Major Scope
- General Oncology
- Gastrointestinal Cancer
- Lymphoma
- Sarcomas
- Bladder Cancer
- Radiation Therapy
- Neoadjuvant Therapy
- Haemato-Oncology
Welcome
Clinics in Oncology™ (Impact Factor: 2.709*) and (ISSN 2474-1663) is an interdisciplinary and borderless journal serves as the most reputable and authoritative platform for distributing key clinical oncology research to its readers, associated with Breast Cancer, Gastrointestinal Cancer, Hematologic Malignancies, Molecular Oncology, Thoracic Cancer, Genitourinary Cancer, Head and neck Cancer, Cervical Cancer, Bladder Cancer, Colon Cancer, Colorectal Cancer, Lung Cancer, Pediatric Cancer, Ovarian Cancer, Prostate Cancer, Surgical Oncology, Pediatric Oncology, Neuro-Oncology, supportive care and quality of life issues, prevention, and phase I and clinical pharmacology. Its readers include active clinical oncologists in practice, researchers, students, trainees, and allied health professionals worldwide.
Clinics in Oncology™ (Impact Factor: 2.709*) encircles a wide range of informative and advanced articles that contribute significantly to the field of oncology. The journal's scope covers various aspects of oncology research, including basic science, translational research, clinical studies, and reviews.
NLM ID
Recently Published Articles
Early Post-Transplant Relapse in a Patient with Transformed Follicular Lymphoma – A Case Report
Abraham SS, Vasudevan JA, Sreemahadevan S, Bharathi JK and Nair SG
Abstract PDF Full Text Case Report | Open Access
Citation: Clin Oncol. 2024;9(1):2066. DOI: 10.25107/2474-1663.2066
Targeting DNA Damage and Repair (DDR) Pathways: Advances in Understanding and Therapeutic Implications
Mudasir Rashid, Rumaisa Rashid, Deverapalli M, Farjana N, Swetha MA, Brim H and Ashktorab H
Abstract PDF Full Text Research Article | Open Access
Citation: Clin Oncol. 2024;9(1):2064. DOI: 10.25107/2474-1663.2064
Castell’s Rapid Desensitization as a Major Therapeutic Opportunity for Patients Experiencing Hypersensitivity Reactions to Antiblastic Drugs
Calabrò C, Carofiglio F, Ferraiuolo S, Laforgia M, Vincenti A, Ungaro V and Nardulli P
Abstract PDF Full Text Research Article | Open Access
Citation: Clin Oncol. 2024;9(1):2063. DOI: 10.25107/2474-1663.2063
MC1R Common Variants and the 10-Year Survival after Melanoma in Polish Population
Dębniak T, Baszuk P, Rowińska K, Feherpataky M, Boer M, Kiedrowicz M, Marchlewicz M, Cybulski C, Jakubowska A, Huzarski T, Lener M, Dębniak A, Białożyt J, Bielawska I, Lubiński J and Gronwald J
Abstract PDF Full Text Research Article | Open Access
Citation: Clin Oncol. 2024;9(1):2061. DOI: 10.25107/2474-1663.2061
Comparing Surgical Outcomes between Conventional Thoracoscopic Esophagectomy vs. Robotic Esophagectomy: A Review
Chin D, Shreya S, Rusidanmu A, Ye P, Zhu X, Zhou K and Huang M
Abstract PDF Full Text Review Article | Open Access
Citation: Clin Oncol. 2024;9(1):2060. DOI: 10.25107/2474-1663.2060
Improving the Teaching-Learning Processes in Team Training Program, Arsi University CHS, Asella Town, Arsi Zone, Oromia Region, Ethiopia, July 2019
Abdeta G, Hailu G, Bekele M, Adem B, Dady L and Bekele N
Abstract PDF Full Text Research Article | Open Access
Citation: Clin Oncol. 2024;9(1):2059. DOI: 10.25107/2474-1663.2059